Association of maximum GVHD grade and biomarker panel with overall survival
| . | Individual . | Simultaneous . | ||
|---|---|---|---|---|
| . | Hazard ratio . | P . | Hazard ratio . | P . |
| Unadjusted | ||||
| Maximum GVHD grade (1/2 vs 3/4) | 2.35 | <.001 | 2.11 | .001 |
| Biomarker panel | 2.46 | <.001 | 2.43 | <.001 |
| Adjusted* | ||||
| Maximum GVHD grade (1/2 vs 3/4) | 2.31 | .002 | 2.06 | .003 |
| Biomarker panel | 2.31 | .001 | 2.28 | .003 |
| . | Individual . | Simultaneous . | ||
|---|---|---|---|---|
| . | Hazard ratio . | P . | Hazard ratio . | P . |
| Unadjusted | ||||
| Maximum GVHD grade (1/2 vs 3/4) | 2.35 | <.001 | 2.11 | .001 |
| Biomarker panel | 2.46 | <.001 | 2.43 | <.001 |
| Adjusted* | ||||
| Maximum GVHD grade (1/2 vs 3/4) | 2.31 | .002 | 2.06 | .003 |
| Biomarker panel | 2.31 | .001 | 2.28 | .003 |
Adjusted for age, donor relation, donor matching, conditioning regimen, and status at transplantation.